[Mechanism of artesunate-induced ferroptosis in triple-negative breast cancer cells through Wnt/β-catenin signaling pathway].

View at publisher
Authors: Ying Huang, Jie-Yi Wu, Jing-Wen Xia, Yuan-Yuan Gao, Peng Li
Cited by: 0

Abstract

This article investigated the effect and mechanism of artesunate(ART) on ferroptosis in triple-negative breast cancer. Triple-negative breast cancer MDA-MB-231 cells and MDA-MB-468 cells were cultured in vitro. The effect of ART at different concentrations on the viability of MDA-MB-231 cells and MDA-MB-468 cells was detected by cell counting kit-8(CCK-8), and the appropriate treatment concentration of ART was screened out. The cells were randomly separated into a control group and groups of ART, ART + ferroptosis inhibitor Ferrostatin-1(Fer-1), ART + ferroptosis inhibitor deferiprone(DFP), and ART + Wnt/β-catenin agonist(SKL2001). The CCK-8 method was used to detect cell viability. Commercial kits were used to detect the release of lactate dehydrogenase(LDH) and the level of glutathione(GSH), superoxide dismutase(SOD), and malondialdehyde(MDA). Immunofluorescence was used to measure the level of reactive oxygen species(ROS) and intracellular Fe~(2+) and the protein expression level of glutathione peroxidase 4(GPX4) and β-catenin. Western blot was used to detect the protein expression of transferrin receptor 1(TFR1), divalent metal transporter 1(DMT1), light polypeptide(FTL), acyl-CoA synthetase long-chain family member 4(ACSL4), solute carrier family 7 member 11(SLC7A11), GPX4, β-catenin, and phosphorylated glycogen synthase kinase 3β(p-GSK-3β). The results showed that the survival rate of MDA-MB-231 cells and MDA-MB-468 cells decreased with increasing ART concentration. Compared with those of the control group, the LDH release rate and the levels of ROS, intracellular Fe~(2+), and MDA were significantly elevated(P

Fields of Study & Subjects

Ferroptosis and cancer prognosis Iron Metabolism and Disorders Ferrocene Chemistry and Applications

Publication details

Journal / source
PubMed
Volume
51
Issue
4
Pages
1053–1063
Publication date
1 February 2026
Language
ZH